Agilent Dr. Oligo Pro II PMA
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Centers for Disease Control and Prevention (CDC), specifically the Biotechnology Core Facility Branch (BCFB), intends to award a sole source, firm fixed-price purchase order to Agilent Technologies Inc. for preventative maintenance services on an Agilent Oligo Pro II system. This notice is an intent to award, not a request for competitive quotes. Capability statements are due by June 22, 2026.
Scope of Work
The contractor will provide annual preventative maintenance services for the Agilent Oligo Pro II system (Serial Number: 21033_1 /MY21201018). Key services include:
- Annual equipment maintenance.
- All labor, travel, and parts, with unlimited breakdown calls.
- One scheduled preventative maintenance visit per year, including a full system diagnostic and exchange of critical parts.
- Priority response for all breakdown calls within 24 to 48 hours. The system is critical for quality control analysis of approximately 8,000 synthesized oligonucleotides annually, supporting CDC researchers in outbreak investigations and FDA-approved kit production.
Contract & Timeline
- Type: Sole Source Intent (Firm Fixed-Price Purchase Order)
- Anticipated Award Date: On or before July 01, 2026
- Period of Performance: July 01, 2026, to June 30, 2029
- NAICS Code: 811210 Electronic and Precision Equipment Repair and Maintenance
- Product Service Code: J066 Maintenance, Repair And Rebuilding Of Equipment: Instruments And Laboratory Equipment
- Set-Aside: None
- Capability Statements Due: June 22, 2026, 3:00 PM EST
- Published: June 15, 2026
Evaluation
This is a notice of intent to award a sole source contract, citing FAR 13.106-1(b)(1)(i) due to Agilent Technologies Inc. being the only responsible source with proprietary parts and specialized engineers. Interested sources must submit a capability statement demonstrating the ability to provide the required warranties and proof of being an authorized distributor. Statements should not exceed two 8.5 x 11 inch pages (10-point font minimum). The Government will consider responses to determine if a competitive procurement is feasible.
Submission Information
Capability statements must be submitted via email ONLY to Javier Aponte at zsm9@cdc.gov as a Microsoft Word or Adobe PDF attachment. No telephone requests or offers will be honored.